14/10/2026 - Research, Success Stories

The CMCiB expands its housing capacity and upgrades infrastructure for biomedical research

The CMCiB, strategic project of IGTP, continues to strengthen its capacity to support biomedical research with the opening of a new rodent housing facility and the upgrading of part of its animal housing systems. This initiative increases the centre's capacity to support researchers, strengthens safety and biocontainment, improves animal welfare and provides more efficient working environments for health research projects.

30/09/2026 - Research

GCAT joins OMega-X, a European consortium studying the impact of working life on health

An article published in the International Journal of Epidemiology presents this European resource, which brings together 24 cohorts from eight countries and multinational studies, with data from more than 20 million participants.

06/08/2026 - Projects, Research

Night shift work linked to a higher risk of long COVID

The first evidence that night work and chronic insomnia may increase the risk of developing long COVID comes from a new study led by ISGlobal, a centre supported by "la Caixa" Foundation, in collaboration with the Germans Trias i Pujol Research Institute (IGTP), through the GCATlGenomes for Life cohort.

15/07/2026 - Campus Can Ruti, Research

New algorithm improves gene expression marker identification across diverse biological systems

Researchers from IGTP, UPC, IrsiCaixa and CIBEREHD have developed the Cartesian Distance-Based Gene Expression (CDBGE) approach, a novel algorithm designed to identify the genes that best distinguish between different biological conditions.

13/07/2026 - Campus Can Ruti, Research

A pilot clinical trial led by Germans Trias provides the first clinical proof of concept for ibuprofen as an adjunctive treatment for tuberculosis

The study, published in Nature Communications, evaluates ibuprofen for the first time in patients with tuberculosis as an adjunctive therapy aimed at modulating the host inflammatory response. The results did not show an improvement in the main clinical or microbiological outcomes, but they did reveal biological changes consistent with reduced inflammation, supporting further investigation of this approach in larger, controlled trials.

09/07/2026 - Campus Can Ruti, Projects, Research

BST and IGTP are advancing the use of the particles that cells use to communicate as revolutionary therapies for the future

Researchers from BST, IGTP and Biosfer Teslab have demonstrated the potential of Nuclear Magnetic Resonance to monitor and optimise the manufacture of extracellular vesicles, one of the most promising therapeutic platforms in regenerative medicine. The findings, published in the Journal of Extracellular Vesicles, could help facilitate the development and scale-up of these therapies.

23/06/2026 - Research

Physical exercise could help modulate the immune response in type 1 diabetes

A review published in Diabetes Care analyses experimental and clinical evidence on the role of physical activity as a potential complementary strategy to promote immune regulation, preserve beta cells and reduce inflammation in type 1 diabetes.

22/06/2026 - Research

IGTP researchers identify a potential therapeutic strategy for malignant tumours associated with neurofibromatosis type 1

The study, published in Nature Communications, develops a new cellular model that reproduces the progression of NF1-associated tumours and enables the identification of new therapeutic opportunities.

17/06/2026 - Projects, Research

GCAT introduces a new open tool to facilitate the reuse of genomic data

The GCAT team at IGTP has developed PolyGenie, a new open tool that enables researchers to explore and reuse genomic data more easily. Designed to support large-scale genetic association studies, the platform advances GCAT's commitment to FAIR data and Open Science. Its development and application to the GCAT cohort are described in NAR Genomics and Bioinformatics.

15/06/2026 - Research

A study supports anal self-sampling as a reliable tool for HPV detection in higher-risk populations

A multicentre study led by professionals from the CEEISCAT and the Institut Català d'Oncologia (ICO-IDIBELL), published in the Journal of Medical Virology, concludes that anal self-sampling for the detection and genotyping of human papillomavirus (HPV) is an accurate, feasible and well-accepted strategy among gay, bisexual and other men who have sex with men (GBMSM) and trans people in the Barcelona metropolitan area.